![]() |
Managed Care CastAuthor: Managed Care Cast
Podcast by Managed Care Cast Language: en Genres: Science Contact email: Get it Feed URL: Get it iTunes ID: Get it |
Listen Now...
Personalized Care Key as Tirzepatide Use Expands Rapidly
Tuesday, 15 April, 2025
Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes. Overall, their findings show a significant uptick in tirzepatide dispensations, alongside other glucose- and weight-lowering medications, including semaglutide.